Infosys hits 3-year high of Rs 3464; BofA-ML pegs it at Rs 4000
Top IT stocks have given solid returns over the last few months. Would it be prudent for investors to exit the sector?
$1 bn bet: GSK Pharma a short-term sell, long-term buy, say experts
The stock is at rich valuations despite low sales and profit growth. The open offer by its parent firm is attractively priced, say experts.
Markets okay with 25 bps hike; but a hawkish RBI may trigger selloff
According to analysts, the RBI's mid quarter review of monetary policy and the US Federal Reserve's meeting is likely to dictate the trend for the markets.
|
No comments:
Post a Comment